KABRADGPharmaceuticals
Kabra Drugs Ltd — Balance Sheet
₹24.58
-3.19%
Kabra Drugs Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 2.37 Cr | 0.44 Cr | 0.44 Cr | 0.44 Cr | — |
| Share Issued | 2.37 Cr | 0.44 Cr | 0.44 Cr | 0.44 Cr | — |
| Total Debt | 0.44 Cr | 1.71 Cr | 1.38 Cr | 1.03 Cr | — |
| Tangible Book Value | 24.65 Cr | 1.08 Cr | -0.73 Cr | -0.39 Cr | — |
| Invested Capital | 25.09 Cr | 2.79 Cr | 0.65 Cr | 0.63 Cr | — |
| Working Capital | 24.59 Cr | 1.06 Cr | -0.75 Cr | -0.42 Cr | — |
| Net Tangible Assets | 24.65 Cr | 1.08 Cr | -0.73 Cr | -0.39 Cr | — |
| Common Stock Equity | 24.65 Cr | 1.08 Cr | -0.73 Cr | -0.39 Cr | — |
| Total Capitalization | 24.65 Cr | 1.08 Cr | -0.73 Cr | -0.39 Cr | — |
| Total Equity Gross Minority Interest | 24.65 Cr | 1.08 Cr | -0.73 Cr | -0.39 Cr | — |
| Stockholders Equity | 24.65 Cr | 1.08 Cr | -0.73 Cr | -0.39 Cr | — |
| Other Equity Interest | 0.95 Cr | 2.55 Cr | — | -4.78 Cr | -4.60 Cr |
| Capital Stock | 23.71 Cr | 4.39 Cr | 4.39 Cr | 4.39 Cr | — |
| Common Stock | 23.71 Cr | 4.39 Cr | 4.39 Cr | 4.39 Cr | — |
| Total Liabilities Net Minority Interest | 0.57 Cr | 3.49 Cr | 1.43 Cr | 1.12 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 4000.00 | 1.00 | 1.00 | 1.00 | — |
| Other Non Current Liabilities | -1000.00 | 1.00 | 1.00 | 1.00 | — |
| Non Current Deferred Taxes Liabilities | 5000.00 | — | — | — | — |
| Long Term Debt And Capital Lease Obligation | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Liabilities | 0.57 Cr | 3.49 Cr | 1.43 Cr | 1.12 Cr | — |
| Other Current Liabilities | 0.14 Cr | 0.05 Cr | — | 0.10 Cr | 0.08 Cr |
| Current Debt And Capital Lease Obligation | 0.44 Cr | 1.71 Cr | 1.38 Cr | 1.03 Cr | — |
| Current Debt | 0.44 Cr | 1.71 Cr | 1.38 Cr | 1.03 Cr | — |
| Payables | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Accounts Payable | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Total Assets | 25.23 Cr | 4.57 Cr | 0.70 Cr | 0.73 Cr | — |
| Total Non Current Assets | 0.07 Cr | 0.02 Cr | 0.02 Cr | 0.02 Cr | — |
| Other Non Current Assets | 0.02 Cr | 0.02 Cr | — | 0.02 Cr | 0.02 Cr |
| Non Current Deferred Taxes Assets | 0.00 | 0.00 | — | 0.00 | 0.00 |
| Investmentin Financial Assets | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Goodwill And Other Intangible Assets | 0.00 | 0.00 | — | 0.00 | 0.00 |
| Net PPE | 0.04 Cr | 0.00 | 0.00 | 0.00 | — |
| Gross PPE | 0.04 Cr | 0.17 Cr | 0.17 Cr | 0.17 Cr | — |
| Other Properties | 0.04 Cr | — | — | — | 0.01 Cr |
| Current Assets | 25.16 Cr | 4.55 Cr | 0.68 Cr | 0.71 Cr | — |
| Other Current Assets | 3.22 Cr | 1.00 | 1.00 | 1.00 | — |
| Inventory | 0.00 | 0.00 | — | 0.00 | 0.00 |
| Accounts Receivable | 0.60 Cr | 0.60 Cr | 0.60 Cr | 0.60 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 21.34 Cr | 2.67 Cr | 29496.00 | 12623.00 | — |
| Other Short Term Investments | 0.04 Cr | 3.75 Cr | — | 9000.00 | 8000.00 |
| Cash And Cash Equivalents | 21.30 Cr | 2.67 Cr | 29496.00 | 12623.00 | — |
| Total Tax Payable | — | 0.00 | — | 0.00 | 0.00 |
| Net Debt | — | 1.59 Cr | 1.38 Cr | 1.02 Cr | 0.89 Cr |
| Retained Earnings | — | -5.86 Cr | -5.12 Cr | -4.78 Cr | -4.60 Cr |
| Additional Paid In Capital | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Long Term Equity Investment | — | 0.00 | — | 0.00 | 0.00 |
| Accumulated Depreciation | — | -0.17 Cr | -0.17 Cr | -0.17 Cr | -0.16 Cr |
| Construction In Progress | — | 0.00 | — | 0.00 | 0.00 |
| Machinery Furniture Equipment | — | 0.17 Cr | 0.17 Cr | 0.17 Cr | 0.17 Cr |
| Assets Held For Sale Current | — | 0.00 | — | 0.00 | — |
| Prepaid Assets | — | 1.28 Cr | 0.08 Cr | 0.10 Cr | 0.10 Cr |
| Other Receivables | — | 0.04 Cr | — | 0.07 Cr | 0.07 Cr |
| Allowance For Doubtful Accounts Receivable | — | -0.12 Cr | -0.12 Cr | -0.12 Cr | -0.12 Cr |
| Gross Accounts Receivable | — | 0.72 Cr | 0.72 Cr | 0.72 Cr | 1.37 Cr |
| Cash Equivalents | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Financial | — | 2.67 Cr | 29496.00 | 12623.00 | 97826.00 |
| Buildings And Improvements | — | — | — | — | 0.00 |
| Land And Improvements | — | — | — | — | 0.00 |
| Properties | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Kabra Drugs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.